Atlas Trials

Treatment and Prevention of Progression of Interstitial Lung Disease in Systemic Sclerosis

Clinical trial NCT01858259 · UNKNOWN

Trial details

NCT number
NCT01858259
Sponsor
Gabriela Riemekasten
Status
UNKNOWN
Study type
OBSERVATIONAL
Systemic SclerosisInterstitial Lung Diseases
Start date
2013-05-01
Primary completion
2016-06-01
Enrollment
1372

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.